Mid-Year Report — THE WASHINGTON GROUP for MENTOR CORPORATION (2007)

Firm

THE WASHINGTON GROUP

Client

MENTOR CORPORATION

Income

$160,000

Expenses

—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring Legislative Process HR 2503 - FDA Scientific Fairness to Women Act

Lobbyist	Covered position, as disclosed
KEVIN ALLEN	N/A
CARLOS BONILLA	N/A
MELISSA M EDWARDS	N/A
KIMBERLEY FARMER	N/A
RITA LEWIS	N/A
PAUL LOBO	N/A
ANTHONY MARKEN	—
MARISSA MITROVICH	N/A
SUSAN MOLINARI	N/A
JAMES NOONE	N/A
G JOHN O'HANLON	N/A
EUGENE PATRONE	N/A
TONYA SAUNDERS	N/A
BRETT SHOGREN	POLICY DIRECTOR, OFFICE OF THE MAJORITY LEADER
HARRY SPORIDIS	N/A
FOWLER WEST	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 2503 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.